Related Experiment Video
Updated: May 25, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue
Hyun Joo Jung1, Zheng Chen, Michael Wang
1Centre for Stem Cell Research, Brown Foundation Institute of Molecular Medicine for Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Blood
|February 2, 2012
Summary
Tissue transglutaminase (TG) activates NF-κB signaling, contributing to bortezomib resistance in mantle cell lymphoma (MCL). Inhibiting TG2 with calcium blockers alongside bortezomib may improve treatment efficacy for MCL patients.
Area of Science:
- Oncology
- Biochemistry
- Cell Signaling
Background:
- Bortezomib is approved for mantle cell lymphoma (MCL) but shows limited efficacy in some patients.
- Developing strategies to overcome bortezomib resistance is crucial for improving patient survival.
Purpose of the Study:
- To investigate the role of tissue transglutaminase (TG) in activating NF-κB signaling pathways in MCL.
- To explore TG2 as a potential therapeutic target to overcome bortezomib resistance in MCL.
Main Methods:
- Biochemical and molecular methodologies were employed to study TG and NF-κB signaling.
- TG2 activity was modified in MCL cells, and its effects on NF-κB were analyzed.
- The combination of a calcium blocker (perillyl alcohol) with bortezomib was tested for cytotoxicity.
Main Results:
- Tissue transglutaminase (TG) was found to activate downstream NF-κB signaling pathways.
- Mantle cell lymphoma (MCL) cells exhibited elevated levels of TG2.
- Inhibiting TG2 signaling with calcium blockers enhanced bortezomib's cytotoxicity in MCL cells by suppressing NF-κB.
Conclusions:
- This study demonstrates TG2's role in NF-κB signaling and its contribution to bortezomib resistance in MCL.
- TG2 inhibition presents a potential therapeutic strategy for MCL.
- Combining calcium blockers with bortezomib may overcome bortezomib resistance in MCL treatment.
Related Concept Videos
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...